Table 4.
< 5 years | 5–9 years | 10–15 years | > 15 years | All samples | |
---|---|---|---|---|---|
Three-level outcomes | |||||
Location (proximal, distal, rectal)a | 0.72 | 0.63 | 0.66 | 0.59 | 0.62 |
KRAS/BRAF (KRAS, BRAF, both wt)a | 0.68 | 0.67 | 0.70 | 0.64 | 0.67 |
Two-level outcomes | |||||
Stage (stages I–II and stages III–IV)b | 0.50 | 0.41 | 0.44 | 0.46 | 0.49 |
KRAS (mutation, wild type)b | 0.50 | 0.47 | 0.42 | 0.44 | 0.50 |
BRAF (mutation, wild type)b | 0.50 | 0.50 | 0.52 | 0.51 | 0.50 |
MSI (MSI, MSS)b | 0.50 | 0.51 | 0.50 | 0.50 | 0.50 |
wt wild type. MSI microsatellite instability. MSS microsatellite stable. None of the potential confounders (body mass index, smoking status, education level, diabetes, alcohol intake, and recreational physical activity) was selected in the variable selection step of the random forest models, with the exception of body mass index in the tumor location analysis restricted to samples taken < 5 years prior to diagnosis. aBalanced error rate for a three-class problem with expected BER by chance of 0.67. bBalanced error rate for a two-class problem with expected BER by chance of 0.50